With IPOs not an option, should pharma feed the biotech ecosystem?

This year's J.P. Morgan Healthcare Conference had its share of bright new ideas and pioneering technologies, tempered by the simple reality that key financial trends on tap for 2012 have already been playing out for several tough years. Report